 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signal transduction
|
PDB id
|
|
|
|
1qqg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
insulin receptor binding
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
96:8378-8383
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the pleckstrin homology-phosphotyrosine binding (PH-PTB) targeting region of insulin receptor substrate 1.
|
|
S.Dhe-Paganon,
E.A.Ottinger,
R.T.Nolte,
M.J.Eck,
S.E.Shoelson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We have determined the crystal structure at 2.3-A resolution of an
amino-terminal segment of human insulin receptor substrate 1 that encompasses
its pleckstrin homology (PH) and phosphotyrosine binding (PTB) domains. Both
domains adopt the canonical seven-stranded beta-sandwich PH domain fold. The
domains are closely associated, with a 720-A(2) contact surface buried between
them that appears to be stabilized by ionic, hydrophobic, and hydrogen bonding
interactions. The nonconserved 46-residue linker between the domains is
disordered. The PTB domain peptide binding site is fully exposed on the
molecular surface, as is a large cationic patch at the base of the PH domain
that is a likely binding site for the head groups of phosphatidylinositol
phosphates. Binding assays confirm that phosphatidylinositol phosphates bind the
PH domain, but not the PTB domain. Ligand binding to the PH domain does not
alter PTB domain interactions, and vice versa. The structural and accompanying
functional data illustrate how the two binding domains might act cooperatively
to effectively increase local insulin receptor substrate 1 concentration at the
membrane and transiently fix the receptor and substrate, to allow multiple
phosphorylation reactions to occur during each union.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Sequence alignment of the amino-terminal domains
of human IRS-1 and IRS-2 and rat IRS-3 and IRS-4. Secondary
structural elements of IRS-1 are shown above the alignments, and
colored green ( -sheets) or
turquoise ( -helices).
Residues of the PTB domain that bind IR are labeled with red
(phosphate binding) or black (all others) squares (13). PH
domain residues forming the cationic patch at its base are
labeled with black squares. Residues that are buried at the
interface between domains are identified either as contributing
to the hydrophobic patch ( ) or as a
specific interaction [e.g., the PH domain residue labeled a
(Arg-75) forms a salt bridge with PTB domain residue a
(Glu-162), etc.]. Note the high degree of residue conservation
at the interface and the great variability in length and
composition of the interdomains of the four proteins.
|
 |
Figure 5.
Fig. 5. Model for insulin signaling through the IR/IRS
axis. (A) Under basal conditions in the absence of insulin, IR
(green) is not phosphorylated (TM, transmembrane domain; JM,
juxtamembrane domain; IRK, IR kinase). IRS (blue) associates
reversibly with PI(4,5)P[2] (red) in the plasma membrane.
Phosphates are represented by the letter P within closed black
circles. (B) Insulin stimulates IR activation, leading to
phosphorylation of three Tyr residues in the activation loop of
IRK and one in the JM NPXY motif. Membrane-bound IRS proteins
associate with the receptor JM, which transiently fixes the two
proteins for phosphorylation of multiple tyrosine residues in
the IRS activation domain.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Bergamin,
P.T.Hallock,
S.J.Burden,
and
S.R.Hubbard
(2010).
The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization.
|
| |
Mol Cell, 39,
100-109.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.Cheng,
Y.Tseng,
and
M.F.White
(2010).
Insulin signaling meets mitochondria in metabolism.
|
| |
Trends Endocrinol Metab, 21,
589-598.
|
 |
|
|
|
|
 |
D.Mahadevan,
G.Powis,
E.A.Mash,
B.George,
V.M.Gokhale,
S.Zhang,
K.Shakalya,
L.Du-Cuny,
M.Berggren,
M.A.Ali,
U.Jana,
N.Ihle,
S.Moses,
C.Franklin,
S.Narayan,
N.Shirahatti,
and
E.J.Meuillet
(2008).
Discovery of a novel class of AKT pleckstrin homology domain inhibitors.
|
| |
Mol Cancer Ther, 7,
2621-2632.
|
 |
|
|
|
|
 |
K.Manikandan,
D.Pal,
S.Ramakumar,
N.E.Brener,
S.S.Iyengar,
and
G.Seetharaman
(2008).
Functionally important segments in proteins dissected using Gene Ontology and geometric clustering of peptide fragments.
|
| |
Genome Biol, 9,
R52.
|
 |
|
|
|
|
 |
S.Y.Park,
and
S.E.Shoelson
(2008).
When a domain is not a domain.
|
| |
Nat Struct Mol Biol, 15,
224-226.
|
 |
|
|
|
|
 |
S.Vorwerk,
C.Schiff,
M.Santamaria,
S.Koh,
M.Nishimura,
J.Vogel,
C.Somerville,
and
S.Somerville
(2007).
EDR2 negatively regulates salicylic acid-based defenses and cell death during powdery mildew infections of Arabidopsis thaliana.
|
| |
BMC Plant Biol, 7,
35.
|
 |
|
|
|
|
 |
P.Radivojac,
S.Vucetic,
T.R.O'Connor,
V.N.Uversky,
Z.Obradovic,
and
A.K.Dunker
(2006).
Calmodulin signaling: analysis and prediction of a disorder-dependent molecular recognition.
|
| |
Proteins, 63,
398-410.
|
 |
|
|
|
|
 |
Y.C.Lin,
G.Liu,
Y.Shen,
C.Bertonati,
A.Yee,
B.Honig,
C.H.Arrowsmith,
and
T.Szyperski
(2006).
NMR structure of protein PA2021 from Pseudomonas aeruginosa.
|
| |
Proteins, 65,
767-770.
|
 |
|
|
|
|
 |
N.Lerner-Marmarosh,
J.Shen,
M.D.Torno,
A.Kravets,
Z.Hu,
and
M.D.Maines
(2005).
Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity.
|
| |
Proc Natl Acad Sci U S A, 102,
7109-7114.
|
 |
|
|
|
|
 |
A.Bennasroune,
A.Gardin,
D.Aunis,
G.Crémel,
and
P.Hubert
(2004).
Tyrosine kinase receptors as attractive targets of cancer therapy.
|
| |
Crit Rev Oncol Hematol, 50,
23-38.
|
 |
|
|
|
|
 |
V.Gervais,
V.Lamour,
A.Jawhari,
F.Frindel,
E.Wasielewski,
S.Dubaele,
J.M.Egly,
J.C.Thierry,
B.Kieffer,
and
A.Poterszman
(2004).
TFIIH contains a PH domain involved in DNA nucleotide excision repair.
|
| |
Nat Struct Mol Biol, 11,
616-622.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Hamada,
T.Shimizu,
S.Yonemura,
S.Tsukita,
S.Tsukita,
and
T.Hakoshima
(2003).
Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex.
|
| |
EMBO J, 22,
502-514.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.C.Stolt,
H.Jeon,
H.K.Song,
J.Herz,
M.J.Eck,
and
S.C.Blacklow
(2003).
Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes.
|
| |
Structure, 11,
569-579.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.H.Hurley,
and
S.Misra
(2000).
Signaling and subcellular targeting by membrane-binding domains.
|
| |
Annu Rev Biophys Biomol Struct, 29,
49-79.
|
 |
|
|
|
|
 |
K.Hamada,
T.Shimizu,
T.Matsui,
S.Tsukita,
and
T.Hakoshima
(2000).
Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain.
|
| |
EMBO J, 19,
4449-4462.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2000).
Skerra A, 2000. Engineered scaffolds for molecular recognition. Journal of Molecular Recognition13:167-187.
|
| |
J Mol Recognit, 13,
409-410.
|
 |
|
|
|
|
 |
J.D.Forman-Kay,
and
T.Pawson
(1999).
Diversity in protein recognition by PTB domains.
|
| |
Curr Opin Struct Biol, 9,
690-695.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|